Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$397.70 USD
-3.06 (-0.76%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $397.89 +0.19 (0.05%) 5:04 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/06/2024
Time: AMC |
3/2024 | $4.10 | -1.17% |
Earnings Summary
For their last quarter, Vertex Pharmaceuticals (VRTX) reported earnings of $4.20 per share, beating the Zacks Consensus Estimate of $4.10 per share. This reflects a positive earnings surprise of 2.44%. Look out for VRTX's next earnings release on May 06, 2024. For the next earning release, we expect the company to report earnings of $4.10 per share, reflecting a year-over-year increase of 34.43%.
Earnings History
Price & Consensus
Zacks News for VRTX
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
VRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services